Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at ...
The novel biosensor technology used in this study can also be transferred to other so-called G protein-coupled receptors (GPCRs), which act as crucial “signal receivers” in our cells and are of major ...
Drug discovery is shifting from static snapshots to moving pictures. Instead of inferring how medicines work from end results ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
A research team of the University Medical Center Mainz has succeeded in observing for the first time how G protein-coupled ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...